Free Trial

10x Genomics (TXG) Earnings Date, Estimates & Call Transcripts

10x Genomics logo
$22.74 +0.73 (+3.31%)
Closing price 03:59 PM Eastern
Extended Trading
$23.19 +0.45 (+1.99%)
As of 06:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

10x Genomics Earnings Summary

10x Genomics posted Q4 2025 earnings on February 12, 2026, reporting an EPS of -$0.13, which beat analysts' consensus estimates of -$0.19 by $0.06. Quarterly revenue rose .6% year-over-year to $166.03 million, above analyst estimates of $160.35 million. With a trailing EPS of -$0.35, 10x Genomics' earnings are expected to grow next year, from ($0.82) to ($0.63) per share.

Upcoming
Earnings Date
May. 7After Market ClosesEstimated
Consensus EPS
(Feb. 12)
-$0.19
Actual EPS
(Feb. 12)
-$0.13 Beat By $0.06
Actual Revenue
(Feb. 12)
$166.03M

Q4 2025 Earnings Resources

TXG Upcoming Earnings

10x Genomics' Q1 2026 earnings is estimated for Thursday, May 7, 2026, based on past reporting schedules, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get 10x Genomics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on 10x Genomics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

TXG Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TXG Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

10x Genomics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue Guidance
Q1 20262-$0.32-$0.23-$0.28
Q2 20262-$0.23-$0.23-$0.23
Q3 20261-$0.24-$0.24-$0.24
Q4 20261-$0.21-$0.21-$0.21

10x Genomics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/7/2026
(Estimated)
-------
2/12/2026Q4 2025-$0.19-$0.13+$0.06-$0.13$160.35M$166.03M
11/6/2025Q3 2025-$0.27-$0.22+$0.05-$0.22$142.50M$149.00M
8/7/2025Q2 2025-$0.35$0.28+$0.63$0.28$139.36M$172.91M
5/8/2025Q1 2025-$0.45-$0.36+$0.09-$0.28$131.91M$154.88M
2/12/2025Q4 2024-$0.32-$0.40 -$0.08-$0.40--
10/29/2024Q3 2024-$0.34-$0.30+$0.04-$0.30$158.84M$151.65M
8/8/2024Q2 2024-$0.47-$0.32+$0.15-$0.32$150.90M$153.10M

Data powered by Fiscal.ai.

10x Genomics Earnings - Frequently Asked Questions

10x Genomics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 7th, 2026 based off last year's report dates. Learn more on TXG's earnings history.

10x Genomics issued an update on its FY 2026 earnings guidance on Thursday, February, 12th. The company issued revenue guidance of $600.0 million-$625.0 million, compared to the consensus revenue estimate of $624.2 million.

In the previous quarter, 10x Genomics (NASDAQ:TXG) reported ($0.13) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.19) by $0.06. Learn more on analysts' earnings estimate vs. TXG's actual earnings.

The conference call for 10x Genomics' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for 10x Genomics' latest earnings report can be read online.
Read Transcript

10x Genomics (NASDAQ:TXG) has a recorded annual revenue of $642.82 million.

10x Genomics (NASDAQ:TXG) has a recorded net income of -$43.54 million. TXG has generated -$0.35 earnings per share over the last four quarters.

10x Genomics' earnings are expected to grow from ($0.82) per share to ($0.63) per share in the next year.


This page (NASDAQ:TXG) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners